Evidence map›Paper›PMID 27461012›Full record

ArticleBMC cancer2016

Transcriptome analysis of paired primary colorectal carcinoma and liver metastases reveals fusion transcripts and similar gene expression profiles in primary carcinoma and liver metastases.

Ja-Rang Lee, Chae Hwa Kwon, Yuri Choi, Hye Ji Park, Hyun Sung Kim, Hong-Jae Jo, Nahmgun Oh, Do Youn Park

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Rapid preliminary purity evaluation of tumor biopsies using deep learning approach.Computational and structural biotechnology journal · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ja-Rang LeeDepartment of Pathology Pusan National University Hospital, Pusan National University School of Medicine, Seo-Gu, Busan, 602-739, Korea.
Chae Hwa KwonDepartment of Pathology Pusan National University Hospital, Pusan National University School of Medicine, Seo-Gu, Busan, 602-739, Korea.
Yuri ChoiDepartment of Pathology Pusan National University Hospital, Pusan National University School of Medicine, Seo-Gu, Busan, 602-739, Korea.
Hye Ji ParkDepartment of Pathology Pusan National University Hospital, Pusan National University School of Medicine, Seo-Gu, Busan, 602-739, Korea.
Hyun Sung KimBioMedical Research Institute Pusan National University Hospital, Seo-Gu, Busan, Korea.
Hong-Jae JoBioMedical Research Institute Pusan National University Hospital, Seo-Gu, Busan, Korea.
Nahmgun OhBioMedical Research Institute Pusan National University Hospital, Seo-Gu, Busan, Korea.
Do Youn ParkDepartment of Pathology Pusan National University Hospital, Pusan National University School of Medicine, Seo-Gu, Busan, 602-739, Korea. pdy220@pusan.ac.kr.
Pusan National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite the clinical significance of liver metastases, the difference between molecular and cellular changes in primary colorectal cancers (CRC) and matched liver metastases is poorly understood.

methodsIn order to compare gene expression patterns and identify fusion genes in these two types of tumors, we performed high-throughput transcriptome sequencing of five sets of quadruple-matched tissues (primary CRC, liver metastases, normal colon, and liver).

resultsThe gene expression patterns in normal colon and liver were successfully distinguished from those in CRCs; however, RNA sequencing revealed that the gene expression between primary CRCs and their matched liver metastases is highly similar. We identified 1895 genes that were differentially expressed in the primary carcinoma and liver metastases, than that in the normal colon tissues. A major proportion of the transcripts, identified by gene expression profiling as significantly enriched in the primary carcinoma and metastases, belonged to gene ontology categories involved in the cell cycle, mitosis, and cell division. Furthermore, we identified gene fusion events in primary carcinoma and metastases, and the fusion transcripts were experimentally confirmed. Among these, a chimeric transcript resulting from the fusion of RNF43 and SUPT4H1 was found to occur frequently in primary colorectal carcinoma. In addition, knockdown of the expression of this RNF43-SUPT4H1 chimeric transcript was found to have a growth-inhibitory effect in colorectal cancer cells.

conclusionsThe present study reports a high concordance of gene expression in the primary carcinoma and liver metastases, and reveals potential new targets, such as fusion genes, against primary and metastatic colorectal carcinoma.

Indexed as

Gene Expression Regulation, NeoplasticOncogene FusionCarcinomaColorectal NeoplasmsDNA-Binding ProteinsGene Expression ProfilingGene Knockdown TechniquesHigh-Throughput Nucleotide SequencingHT29 CellsHumansLiver NeoplasmsOligonucleotide Array Sequence AnalysisOncogene ProteinsRepressor ProteinsRNA InterferenceRNA, Small InterferingDNA-Binding ProteinsOncogene ProteinsRepressor ProteinsRNA, Small InterferingRNF43 protein, humanSUPT4H1 protein, humanUbiquitin-Protein LigasesColorectal cancerExpression profilingGene fusionRNA-seq

Identifiers

PMID27461012
PMCPMC4962348
OpenAlexW2487783610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.